Pay in 4 interest-free payments of $81.00 Learn more
Ships within 48 hours · Estimated delivery Jul 25 - Jul 30
Acquired Resistance to 17-Allylamino-17-Demethoxygeldanamycin (17-AAG
912545-86-9
As a broad spectrum CDK inhibitor
3-c]pyridin-5-yl)-3-(benzyloxy)-1-oxopropan-2-yl)-2-methylpropanamide (2R
ST 2825 - CAS# 894787-30-5 Size:Solid 2 mg Acquired Resistance to 17-Allylamino-17-Demethoxygeldanamycin (17-AAGST 2825 is MyD88 inhibitor. ST2825 provides neuroprotection after experimental traumatic brain injury in mice. ST2825 significantly inhibited the proliferation of and promoted the apoptosis of HCC cells. Moreover, ST2825 significantly decreased bcl 2 expression, increased cleaved caspase 3 expression (P < 0. 05), and reduced p65 nuclear expression (P < 0. 05) in a dose dependent manner. ST2825 inhibits the proliferation of and promotes the apoptosis